Literature DB >> 2896732

Difficult streptococci.

R E Warren1.   

Abstract

Streptococci pose difficulties in laboratory and clinical diagnosis and in therapy. They are important pathogens with both potential for high mortality in acute infections and endocarditis, and recurrence and persistence in foreign-body associated infections. Prevention of serious infection and spread of infection pose a number of hospital problems but hospital difficulties may originate in community wide outbreaks which also require investigation and control. Our experience with septicaemia caused by Lancefield Group A streptococci, and with Group D streptococcal bacteraemia in liver transplant recipients are reported and both national and international problems with antibiotic resistant streptococci are reviewed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896732     DOI: 10.1016/0195-6701(88)90210-1

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

Review 1.  Enterococcus faecium in hospitals.

Authors:  J J Wade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-02       Impact factor: 3.267

2.  Infections after auxiliary partial liver transplantation. Experiences in the first ten patients.

Authors:  J H van Zeijl; A C Kroes; H J Metselaar; P J Willemse; H A Bruining; J F Sluiters; S W Schalm; O T Terpstra; M F Michel
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

Review 3.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients.

Authors:  J W Gray; D Stewart; S J Pedler
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool.

Authors:  A G Miranda; K V Singh; B E Murray
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.